Tear duct implant effective at reducing pain and inflammation in cataract surgery patients

(American Academy of Ophthalmology) The first tear duct implant developed to treat inflammation and pain following cataract surgery has been shown to be a reliable alternative to medicated eye drops, which are the current standard of care, according to a study presented today at AAO 2014, the 118th annual meeting of the American Academy of Ophthalmology.